An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalization or death by 89% in vulnerable adults, clinical trial results suggest.
The drug — called Paxlovid — is aimed at the elderly and others at high risk of severe disease. It comes a day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).
The UK has already ordered 250,000 doses of the new Pfizer treatment along with another 480,000 doses of the MSD pill.
The Pfizer drug, known as a protease inhibitor, is designed to block an enzyme the virus needs in order to multiply. It works slightly differently to the Merck pill which introduces errors into the genetic code of the virus.
Pfizer said it plans to submit interim trial results for its pill to the US medicines regulator, the FDA, as part of the emergency use application it started last month.
Pfizer also says it stopped trials early as the initial results were so positive.
It’s that time of year for the Under My Skin For Life Foundation (UMSFL) to help the children and the families at Unterberg Children’s Hospital at Monmouth Medical Center!
Unwrapped toys will be collected through December 13 and delivered on December 19, 2021. Drop-off points:
Tattoo Tony’s Under My Skin Tattoo Studio
73 Memorial Pkwy, Atlantic Highlands
Speedway’s All Star Bagel Stop
607 Route 539, New Egypt
George Wall Ford Lincoln
700 Shrewsbury Ave, Red Bank
Jackson Moose Lodge
1240 E Veterans Hwy, Jackson Township